Viking Stock Jumps After Company Speeds Development Its Weight-Loss Pill -- Barrons.com

Barron'sJul 25 11:03 ET

ServiceNow Turns Heads With Impressive Results, Rev Gains on Gen-AI

Seeking AlphaJul 25 09:11 ET

Merck KGaA to Sell Surface Solutions Unit for EUR665 Million

MT NewswiresJul 25 08:39 ET

Preventive monoclonal antibody from Merck (MRK.US) achieves positive results, used for preventing infant RSV infection.

Merck (MRK.US) announced that the investigational respiratory syncytial virus (RSV) prophylactic monoclonal antibody clesrovimab (MK-1654) has obtained positive results in phase 2b/3 clinical trials.

Zhitong FinanceJul 24 09:11 ET

Acquiring the company for over 1.3 billion US dollars! Merck's (MRK.US) new small-molecule cancer drug has entered phase 3 clinical trials in China.

According to the latest announcement by China's drug clinical trial registration and information disclosure platform, Merck (MRK.US) has initiated a Phase III clinical study for a new oral drug, MK-3543 (bomedemstat), for the treatment of primary thrombocytosis.

Zhitong FinanceJul 24 04:58 ET

Merck & Co To Go Ex-Dividend On September 16th, 2024 With 0.77 USD Dividend Per Share

Moomoo NewsJul 23 19:45 ET